Ignite Creation Date:
2025-12-24 @ 3:14 PM
Ignite Modification Date:
2026-02-02 @ 12:18 AM
Study NCT ID:
NCT01568892
Status:
COMPLETED
Last Update Posted:
2018-07-02
First Post:
2012-03-29
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Assessing Dolutegravir in HIV-1 Infected Subjects With Virus Resistant to Raltegravir and/or Elivitegravir
Sponsor:
ViiV Healthcare
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
116529
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None